| Literature DB >> 32560736 |
Li-Qun Wang1, Ting-Li Liu1, Pan-Hong Liang1, Shao-Hua Zhang1, Tao-Shan Li1, Yan-Ping Li1, Guang-Xue Liu1, Li Mao1, Xue-Nong Luo2,3.
Abstract
BACKGROUND: Taenia pisiformis is one of the most common intestinal parasites in canines, and leads to serious economic losses in the rabbit breeding industry. Exosome-like vesicles from parasites play crucial roles in host-parasite interactions by transferring cargo from parasites to host cells and by modulating host immunological response through inducing production of host-derived cytokines. Nevertheless, the mechanism by which exosome-like vesicles from T. pisiformis cysticercus regulate the macrophage immune response remains unknown.Entities:
Keywords: Cysticercus pisiformis; Exosome-like vesicles; Macrophages; Th2-type immune response
Mesh:
Substances:
Year: 2020 PMID: 32560736 PMCID: PMC7304098 DOI: 10.1186/s13071-020-04186-z
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Characterization of exosome-like vesicles secreted by T. pisiformis cysticercus. a Morphological characterization of T. pisiformis cysticercus exosome-like vesicles by TEM. The arrowheads indicate exosome-like vesicles stained with phosphotungstic acid. The dotted box portion represents a vesicle with a bi-layered membrane. b NTA diameter distribution analysis of the purified exosome-like vesicles
Fig. 2Functional enrichment analysis of protein cargo enriched in T. pisiformis cysticercus exosome-like vesicles. Bar plot showing biological process, cellular component, and molecular function GO categories in exosome-like vesicles derived from T. pisiformis cysticercus
List of top 50 parasite-derived proteins identified in the proteome of exosome-like vesicles from T. pisiformis cysticercus
| Accession | Annotation | No. of unique peptides | No. of unique spectra |
|---|---|---|---|
| Chaperones | |||
| EUB56318.1 | 6 | 9 | |
| EUB64499.1 | Beta-soluble NSF attachment protein | 4 | 4 |
| Cytoskeletal/Structural proteins | |||
| EUB56079.1 | 9 | 10 | |
| EUB64035.1 | Moesin/ezrin/radixin | 7 | 10 |
| EUB54636.1 | Rab | 6 | 9 |
| EUB61143.1 | Tubulin beta-3 chain | 6 | 6 |
| EUB57627.1 | Rab GDP dissociation inhibitor alpha | 4 | 4 |
| Extracellular matrix/secrected proteins | |||
| EUB61528.1 | Basement membrane-specific heparan sulfate proteoglycan core protein | 5 | 5 |
| EUB57979.1 | Exocyst complex component 3 | 5 | 5 |
| Hypothetical proteins | |||
| EUB54981.1 | Putative phospholipid-transporting ATPase IIB | 13 | 14 |
| EUB54777.1 | Hypothetical protein EGR_10354 | 6 | 6 |
| Metabolic Enzymes | |||
| CDS19796.1 | 9 | 9 | |
| CDS18138.1 | V type proton ATPase 116 kDa subunit a | 5 | 6 |
| CDS15195.1 | Tryptophanyl tRNA synthetase | 4 | 5 |
| EUB61757.1 | Peptidyl-prolyl cis-trans isomerase | 4 | 5 |
| tr|W8P1J2|W8P1J2_TAESO | Phosphoenolpyruvate carboxykinase | 4 | 6 |
| tr|D2U5C3|D2U5C3_TAESO | Long chain fatty acid coenzyme A ligase 5 | 3 | 4 |
| EUB60416.1 | Long-chain-fatty-acid–CoA ligase | 3 | 4 |
| CDS17202.1 | Fructose 1 6 bisphosphate aldolase | 3 | 3 |
| Protease | |||
| EUB64462.1 | Calpain-A | 10 | 10 |
| CDS21212.1 | cGMP dependent protein kinase | 9 | 10 |
| CDS24569.1 | Intestinal type alkaline phosphatase 1 | 4 | 4 |
| EUB59398.1 | 3 | 4 | |
| EUB58966.1 | Ras gtpase | 3 | 4 |
| Signal Transduction and Biological Regulation | |||
| EUB64724.1 | 6 | 6 | |
| EUB62107.1 | 5 | 5 | |
| EUB64038.1 | Vacuolar protein sorting-associated protein 4A | 6 | 6 |
| EUB59108.1 | Transforming protein RhoA | 4 | 6 |
| EUB63467.1 | Receptor Mediated Endocytosis family member | 5 | 5 |
| CDS21096.1 | Endophilin B1 | 4 | 5 |
| EUB57999.1 | Ras-related C3 botulinum toxin substrate 2 | 4 | 5 |
| EUB64797.1 | Ras-related protein O-RAL | 4 | 5 |
| EUB63534.1 | Ras-related protein Rap-1b | 4 | 4 |
| EUB64384.1 | 4 | 4 | |
| EUB59848.1 | ADP-ribosylation factor | 4 | 4 |
| EUB60984.1 | 3 | 4 | |
| Transporters/Channels | |||
| EUB57119.1 | Sodium/potassium-transporting ATPase subunit alpha | 20 | 20 |
| CDS23982.1 | Major vault protein | 9 | 9 |
| EUB60605.1 | Solute carrier family 5 | 5 | 6 |
| CDS22870.1 | Lipid transport protein N terminal | 5 | 6 |
| EUB61207.1 | BRO1 domain containing protein BROX | 4 | 5 |
| EUB62853.1 | Ras-related protein Rab-2A | 4 | 4 |
| EUB62794.1 | Otoferlin | 4 | 4 |
| Others | |||
| EUB53928.1 | Ubiquitin | 6 | 13 |
| EUB62510.1 | 7 | 8 | |
| EUB62111.1 | Tetracycline resistance leader peptide TetL | 6 | 6 |
| EUB64561.1 | Multidrug resistance protein | 6 | 6 |
| EUB63692.1 | Myoferlin | 5 | 6 |
| EUB59451.1 | NEDD4 E3 ubiquitin protein ligase WWP1 | 4 | 6 |
| EUB59351.1 | Tegumental proteins | 3 | 3 |
Note: Both unique peptide number and unique spectra number ≥ 3 are listed. Proteins listed in bold font represent the most common proteins of the “top 30” exosomes-like vesicles in ExoCarta
Fig. 3Western blot of exosomal markers 14-3-3 and enolase. Western blot revealed 14-3-3 with an expected size of approximately 28 kDa and enolase with an expected size of approximately 54 kDa. Both ESP and SAg served as positive controls
Fig. 4Length distribution of annotated miRNAs in exosome-like vesicles and cysticercus of T. pisiformis. a, b All the mapped clean reads were annotated, including miRNAs, rRNAs, tRNAs, snRNAs and snoRNAs. Pie-charts of annotated small RNAs and their percentages in exosome-like vesicles and cysticercus of T. pisiformis. c Common miRNAs in exosome-like vesicles and cysticercus of T. pisiformis. d Length distribution of identified miRNAs
Fig. 5qPCR identification of relevant expression of miRNAs in exosome-like vesicles and cysticercus of T. pisiformis. a Relevant expression of miRNAs in T. pisiformis cysticercus exosome-like vesicles. b Relevant expression of miRNAs in T. pisiformis cysticercus. Cel-miR-39-3p served as an external control to normalize sample-to-sample variation
Fig. 6KEGG pathway classification and functional enrichment of predicted target genes of exosomal miRNAs. The number of proteins in each category is indicated next to the bars
Fig. 7Fold regulation (qPCR) in M1 and M2 cytokine gene expression induced by T. pisiformis cysticercus exosome-like vesicles in RAW264.7 macrophages. LPS and IL-4 served as positive controls for M1 phenotype and M2 phenotype molecules, respectively. PBS served as the negative control for cytokine stimulaton. a, b, g Induction of M1 markers in RAW264.7 macrophages treated with T. pisiformis cysticercus exosome-like vesicles. c-f, h Induction of M2 markers in RAW264.7 macrophages by T. pisiformis cysticercus exosome-like vesicles. Data for the final analysis are from three independent experiments and are expressed as the mean ± standard error (SE). *P < 0.05, **P < 0.01 and ***P < 0.001 were considered statistically significant compared to PBS-treated RAW264.7 macrophages. #P < 0.05, ##P < 0.01 and ###P < 0.001 were considered statistically significant compared to LPS/IL-4 treated RAW264.7 macrophages (Additional file 5: Table S9)
Fig. 8T. pisiformis cysticercus exosome-like vesicles stimulated production of M2 cytokines in RAW264.7 macrophages. LPS and IL-4 served as positive controls for M1 phenotype and M2 phenotype molecules, respectively. PBS served as the negative control for cytokine stimulation. a, b Induction of M1 markers in RAW264.7 macrophages treated with T. pisiformis cysticercus exosome-like vesicles. c-f Induction of M2 markers in RAW264.7 macrophages by T. pisiformis cysticercus exosome-like vesicles. Data for the final analysis are from three independent experiments and are expressed as the mean ± standard error (SE). *P < 0.05, **P < 0.01 and ***P < 0.001 were considered statistically significant compared to PBS-treated RAW264.7 macrophages. #P < 0.05, ##P < 0.01 and ###P < 0.001 were considered statistically significant compared to LPS/IL-4 treated RAW264.7 macrophages (Additional file 6: Table S10)